Table of Contents
Research & Development
AbbVie Signs Immuno-Oncology Partnership with Neomorph for US$1.64 B | Abstract pdf html |
Swati Sharan |
AbbVie Collaborates with Xilio Therapeutics to Develop Antibody-Based Immunotherapies | Abstract pdf html |
Amit Kaushik |
Incyte and Genesis Therapeutics Sign US$620 M AI-focused Collaboration | Abstract pdf html |
Lucy Haggerty |
Mergers & Acquisitions
GSK Pays US$1.15 B To Acquire IDRx | Abstract pdf html |
Ayush Saxena |
Novartis Regains Abelacimab Through US$3.1 B Acquisition of Anthos Therapeutics | Abstract pdf html |
Lucy Haggerty |

This work is licensed under a Creative Commons Attribution 3.0 License.